Page URL: https://www.bionews.org.uk/page_92113

DNA sequences linked to 'spine-fusing' arthritis

16 January 2010
Appeared in BioNews 541
An international consortium composed of research groups in America, England and Australia has published its work in January's edition of the Nature Genetics journal, identifying six genetic regions associated with the autoimmune sidease ankylosing spondylitis (AS).

AS is a chronic arthritic condition, which is thought to be affecting 2.4 million people in the US alone. It is a systemic autoimmune disease meaning that the body's own immune system starts to attack itself, in turn causing an overactive inflammatory response, which can then cause joints to swell and become painful. AS attacks the spine specifically and has an early age onset with many patients experiencing back pain in their teenage years. Over time the spine stiffens and can end up becoming fixed, resulting in the patient being hunched over in a forward position, unable to bend or move freely. Little is known about the causes of AS and the current treatment options of painkillers, physiotherapy and expensive antibody therapy only address the symptoms.

The groups in Texas, Oxford and Queensland completed a genome-wide association scan of over 2000 people with more than 5000 matched controls. They found six genetic regions to be linked to AS with two in particular showing strong correlation; ANTXR2 and IL1R2, which are both known to be involved in regulating inflammatory processes with IL1R2 already being shown to be implicated in psoriasis and inflammatory bowel syndrome. The groups also found two 'desert DNA' regions on chromosomes two and 21, which are thought to regulate the genes responsible for causing AS.

'We have identified regions of our DNA that are strongly associated with susceptibility to ankylosing spondylitis,' says Professor Paul Wordsworth of Oxford University's Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences. 'This helps us better understand what is driving this disease and gives us direction for new treatments and diagnostic tests. There are many theories as to what triggers this condition but understanding which genes are involved is a major step forward which could lead both to new treatments but especially earlier diagnosis, which is badly needed in ankylosing spondylitis as some patients can wait up to a decade to be properly diagnosed' explained Dr John D Reveille, the study's principal investigator and professor and director of the Division of Rheumatology and Clinical Immunogenetics at The University of Texas Medical School at Houston, US.
SOURCES & REFERENCES
Genetic regions linked to arthritis identified
The Times of India |  11 January 2010
Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci
Nature Genetics |  10 January 2010
Hope for spine-fusing arthritis
BBC News |  11 January 2010
New study identifies six genetic regions linked to ankylosing spondylitis
TopNews US |  11 January 2010
Rheumatologists Advance Genetic Research Related to Disabling Form of Arthritis
Science Daily |  11 January 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
9 July 2012 - by Helen Brooks 
Scientists have identified eight regions of the genetic code associated with an increased risk of developing osteoarthritis...
12 September 2011 - by Dr Nadeem Shaikh 
A single gene may play a major role in how we perceive pain, UK scientists have discovered. Research published in the journal Science, by a team from the University of Cambridge, shows that the HCN2 gene may be a vital target for future pharmacological research into pain relief...
18 July 2011 - by Sarah Pritchard 
A team of international researchers have identified several new genetic variants that are involved in a type of incurable spine arthritis – ankylosing spondylitis (AS) – offering hope for novel treatments for those with the condition...
21 June 2010 - by Louise Mallon 
A recent study has shown a rare genetic mutation in a single gene is linked to several different autoimmune diseases, including Type 1 diabetes, lupus and rheumatoid arthritis...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.